




Searching News Database: Central Serous Chorioretinopathy
HSMN NewsFeed - 5 Aug 2015
Ohr Pharmaceutical Promotes Jason S. Slakter, MD to Chief Executive Officer
Ohr Pharmaceutical Promotes Jason S. Slakter, MD to Chief Executive Officer
HSMN NewsFeed - 19 Mar 2012
QLT Receives Orphan Drug Designation for Visudyne for Treatment of Central Serous Chorioretinopathy
QLT Receives Orphan Drug Designation for Visudyne for Treatment of Central Serous Chorioretinopathy
HSMN NewsFeed - 26 Jun 2006
Lumenis Invests in Exclusive, Worldwide License for New Ophthalmic Technology
Lumenis Invests in Exclusive, Worldwide License for New Ophthalmic Technology